The 20 Best Acute Erythroid Leukemia (AEL) Doctors Near Me

Juerg Schwaller practices in Basel, Switzerland. Schwaller is rated as an Elite expert by MediFind in the treatment of Acute Erythroid Leukemia (AEL). Their top areas of expertise are Acute Erythroid Leukemia (AEL), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Acute Myeloid Leukemia (AML).

Thomas Mercher practices in Paris, France. Mr. Mercher is rated as an Elite expert by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Acute Megakaryoblastic Leukemia, Acute Erythroid Leukemia (AEL), Acute Myeloid Leukemia (AML), and Leukemia.

Matheus Bezerra practices in Recife, Brazil. Mr. Bezerra is rated as an Elite expert by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Acute Erythroid Leukemia (AEL), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Plague.

Alexandar Tzankov practices in Basel, Switzerland. Mr. Tzankov is rated as an Elite expert by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Acute Erythroid Leukemia (AEL), Thymectomy, and Bone Marrow Transplant.

Sabine Juge practices in Basel, Switzerland. Ms. Juge is rated as an Elite expert by MediFind in the treatment of Acute Erythroid Leukemia (AEL). Her top areas of expertise are Acute Erythroid Leukemia (AEL), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Acute Myeloid Leukemia (AML).

Robert Ivanek practices in Basel, Switzerland. Mr. Ivanek is rated as an Elite expert by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Acute Erythroid Leukemia (AEL), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Acute Myeloid Leukemia (AML).

. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Angiosarcoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Iron Deficiency Anemia.

To provide state of the art medical care for our patients in a friendly, and compassionate setting. Dr. Shirinian is rated as a Distinguished provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Acute Erythroid Leukemia (AEL), Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

Asterios Tsiftsoglou practices in Thessaloniki, Greece. Tsiftsoglou is rated as a Distinguished expert by MediFind in the treatment of Acute Erythroid Leukemia (AEL). Their top areas of expertise are Acute Erythroid Leukemia (AEL), Cytochrome C Oxidase Deficiency, Myelofibrosis, and Acute Myeloid Leukemia (AML).

Gerhard Ehninger practices in Dresden, Germany. Mr. Ehninger is rated as a Distinguished expert by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant.

Martin Bornhauser practices in Dresden, Germany. Mr. Bornhauser is rated as a Distinguished expert by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Bone Graft.

Malgorzata Mcmasters is an Internal Medicine provider in Boston, Massachusetts. Dr. Mcmasters is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myelomonocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant.

David Avigan is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Avigan is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Alexander J. Ambinder is an instructor of medicine at the Johns Hopkins University School of Medicine. He is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer at Johns Hopkins. Dr. Ambinder has expertise in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and bone marrow transplantation. Dr. Ambinder received his B.A. from Washington University in St. Louis. He earned his M.D. from Emory University School of Medicine and his M.P.H. from Emory University Rollins School of Public Health. He completed the Osler Medical Residency Training Program in internal medicine at Johns Hopkins and subsequently served as an Assistant Chief of Service (Chief Resident). He completed his fellowships in Hematology and Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and also served as a Chief Fellow. Dr. Ambinder is a member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Ambinder’s principle research interest is in designing and conducting clinical trials inspired by laboratory insights to improve the management of acute myeloid leukemia and myelodysplastic syndrome. He also has an interest in building large databases that will yield insights that allow for more personalized approaches to the care and treatment of patients with blood cancers. Dr. Ambinder is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Joseph Rimando is a Hematologist in Atlanta, Georgia. Dr. Rimando has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Acute Erythroid Leukemia (AEL), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Leukemia, and Bone Marrow Transplant.

Dr. DeZern is a Professor of Oncology and Medicine at The Johns Hopkins University School of Medicine. She is active in the Division of Hematology Malignancies, Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Dr. DeZern has expertise in aplastic anemia, myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, acute myeloid leukemia, and bone marrow transplantation. Dr. DeZern received her medical degree at The Johns Hopkins University School of Medicine. She completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology and hematology, as well as obtained a Masters in Clinical Investigations at the Bloomberg School of Public health. Dr. DeZern is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the American Society for Transplantation and Cellular Therapy. Dr. DeZern’s principle research activities consist of designing and conducting clinical trials that test investigational new therapies and approaches in the treatment of bone marrow failure (aplastic anemia and myelodysplastic syndromes). She has specific expertise in the use of alternative donor bone marrow transplantation in patients with severe aplastic anemia and trials of novel therapeutics for patients with myelodysplastic syndromes. Additionally, she has taken a rigorous approach to the study of diagnostics and supportive case (such as transfusion practices) in these patient populations. She is or has been the Principal Investigator for a number of multicenter trials in collaboration with the MDS Clinical Research Consortium, the Eastern Co-operative Oncology Group (ECOG)-ACRIN and now the Bone Marrow Trials Clinical Trials Network (BMTCTN). She is the Study Chair for the multi-site BMTCTN study (CHAMP) investigating the role of haploidentical donor transplantation using post-transplantation cyclophosphamide in patients with relapsed several aplastic anemia. Dr. DeZern is the local PI as well as the Deputy Chair for The National MDS Study, a collaborative natural history study of the NHLBI and the NCI. As a clinical investigator with a focus on translation of novel treatments to the clinic, Dr. DeZern’s goal is to improve outcomes for patients with bone marrow failure at the bedside and in her research environment. Dr. Dezern is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). Her top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Ivana Gojo is a Hematologist/Oncologist in Baltimore. Her clinical focus is on diagnosis and management of patients with acute leukemias (AML, ALL) and other myeloid malignancies (MDS, MPNs, CML), with emphasis on the development of novel therapeutic approaches for these diseases. She is nationally and internationally recognized expert in clinical translation of novel therapeutics for acute leukemias and principal investigator on multiple multi-center investigator-initiated studies. Dr. Gojo joined the Johns Hopkins faculty in 2012 as the Co-Director of Leukemia Drug Development Program. She has served on the National Cancer Institute (NCI) Investigational Drug Steering Committee since 2014. Dr. Gojo received a Service Star Award from Johns Hopkins Medicine Service Excellence in 2018 for her exemplary care of leukemia patients. Dr. Gojo contributed to the clinical translational and drug development effort of multiple novel agents targeting pathogenic pathways in patients with acute leukemia. Her research efforts are now concentrated on the development and integration of novel immunotherapies into therapeutic armamentarium for patients with acute leukemia. She mentors basic and clinical research fellows and junior faculty on the development and design of novel clinical trials and mechanistic laboratory studies associated with these trials. She served as a leukemia team leader on the National Institute of Health (NIH)/NCI N01 grant (Phase II consortium) (2009-2011), and is co-principal investigator (PI) on the Experimental Therapeutics (ET)-Clinical Trial Network (CTN) UM1 grant supporting early clinical trials. Dr. Gojo has served on the National Comprehensive Cancer Network guideline panel for AML since 2019, Myeloid Growth Factor guideline panel since 2015 and previously served on the MPNs guideline panel (2016-2019). She has extensive experience in the regulatory aspects of drug development and served as the Chair (2015-2016) and Co-Chair (2014-2015) of the Cancer Research Review Committee at Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, and serves as a member of the SKCCC Biostatistics Core Advisory Committee and SKCCC Clinical Research Office Coordinating Center Oversight Committee. Dr. Gojo is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Benjamin Ebert is an Oncologist in Boston, Massachusetts. Dr. Ebert is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Myelodysplastic Syndrome (MDS), Pure Red Cell Aplasia, Leukemia, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.

Jaroslaw Maciejewski is a Hematologist in Cleveland, Ohio. Dr. Maciejewski is rated as an Advanced provider by MediFind in the treatment of Acute Erythroid Leukemia (AEL). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Paroxysmal Cold Hemoglobinuria, Bone Marrow Transplant, and Splenectomy.